{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:55:22Z","timestamp":1790625322781,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Primary renal Ewing sarcoma (EWS) is a rare but aggressive pediatric malignancy with poor outcomes and limited knowledge of its behavior and biology. The use of molecular markers as prognostic factors and local control strategies with surgical resection and radiation is not well-described for renal EWS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Observation:<\/jats:title>\n                    <jats:p>We document a case of stage IV renal EWS with 4.5 years of durable remission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      We hypothesize the favorable outcome may be associated with the lack of specific genomic signatures (\n                      <jats:italic toggle=\"yes\">STAG2<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">CDKN2A<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                      ) and the use of upfront surgical resection followed by radiation for local control.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mph.0000000000003244","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T21:01:41Z","timestamp":1782766901000},"page":"e314-e317","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Role of STAG2, CDKN2A, and TP53 Genes in Ewing Sarcoma: A Report of a Rare Case of Primary Ewing Sarcoma of the Kidney With Favorable Outcome"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4867-5002","authenticated-orcid":false,"given":"Alyssa M.","family":"Greenwell","sequence":"first","affiliation":[{"name":"Children\u2019s Hospital of Michigan, Division of Pediatric Hematology Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avanti","family":"Gupte","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Michigan, Division of Pediatric Hematology Oncology"},{"name":"Central Michigan University College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali G.","family":"Saad","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Michigan, Division of Pediatric Hematology Oncology"},{"name":"Wayne State University School of Medicine, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza S.","family":"Gorsi","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Michigan, Division of Pediatric Hematology Oncology"},{"name":"Central Michigan University College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"R1-20260928","doi-asserted-by":"crossref","first-page":"488","DOI":"10.21037\/tcr-22-70","article-title":"Molecular profiling of gene fusions in soft tissue sarcomas by Ion AmpliSeq(TM): a study of 35 cases","volume":"11","author":"Wei","year":"2022","journal-title":"Transl Cancer Res"},{"key":"R2-20260928","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.urology.2012.10.016","article-title":"Ewing sarcoma of the kidney: case series and literature review of an often overlooked entity in the diagnosis of primary renal tumors","volume":"81","author":"Rowe","year":"2013","journal-title":"Urology"},{"key":"R3-20260928","doi-asserted-by":"crossref","first-page":"e1004475","DOI":"10.1371\/journal.pgen.1004475","article-title":"The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation","volume":"10","author":"Brohl","year":"2014","journal-title":"PLoS Genet"},{"key":"R4-20260928","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1038\/s44319-024-00303-6","article-title":"STAG2 loss in Ewing sarcoma alters enhancer-promoter contacts dependent and independent of EWS::FLI1","volume":"25","author":"Gim\u00e9nez-Llorente","year":"2024","journal-title":"EMBO Rep"},{"key":"R5-20260928","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/1878-0261.70008","article-title":"Revisiting CDKN2A dysregulation in Ewing sarcoma","volume":"19","author":"Paragji","year":"2025","journal-title":"Mol Oncol"},{"key":"R6-20260928","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-14-0622","article-title":"Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations","volume":"4","author":"Tirode","year":"2014","journal-title":"Cancer Discov"},{"key":"R7-20260928","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3892\/ol.2021.12615","article-title":"Extraskeletal Ewing sarcoma: diagnosis, management and prognosis","volume":"21","author":"Abboud","year":"2021","journal-title":"Oncol Lett"},{"key":"R8-20260928","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijscr.2017.07.065","article-title":"Primary Ewing\u2019s sarcoma of the kidney: a case report","volume":"41","author":"Alasmari","year":"2017","journal-title":"Int J Surg Case Rep"},{"key":"R9-20260928","doi-asserted-by":"crossref","first-page":"1512474","DOI":"10.3389\/fsurg.2025.1512474","article-title":"Renal Ewing sarcoma in a young female: a case report and review of targeted therapy","volume":"12","author":"Wang","year":"2025","journal-title":"Front Surg"},{"key":"R10-20260928","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4103\/ua.ua_2_23","article-title":"A primary Ewing\u2019s sarcoma of the kidney: a case report and review of literature","volume":"15","author":"Senkhum","year":"2023","journal-title":"Urol Ann"},{"key":"R11-20260928","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra2028910","article-title":"Ewing\u2019s sarcoma","volume":"384","author":"Riggi","year":"2021","journal-title":"N Engl J Med"},{"key":"R12-20260928","doi-asserted-by":"crossref","first-page":"W12","DOI":"10.1308\/147870808X303146","article-title":"Very late local recurrence of Ewing\u2019s sarcoma\u2013can you ever say \u2018cured\u2019? A report of two cases and literature review","volume":"90","author":"Hanna","year":"2008","journal-title":"Ann R Coll Surg Engl"},{"key":"R13-20260928","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/gcc.22336","article-title":"Ewing sarcoma with ERG gene rearrangements: a molecular study focusing on the prevalence of FUS-ERG and common pitfalls in detecting EWSR1-ERG fusions by FISH","volume":"55","author":"Chen","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"R14-20260928","doi-asserted-by":"crossref","first-page":"397632","DOI":"10.1155\/2010\/397632","article-title":"Is there a predisposition gene for Ewing\u2019s sarcoma?","volume":"2010","author":"Randall","year":"2010","journal-title":"J Oncol"},{"key":"R15-20260928","doi-asserted-by":"crossref","first-page":"rjae390","DOI":"10.1093\/jscr\/rjae390","article-title":"Primary Ewing sarcoma of the kidney: a rare entity with diagnostic challenges","volume":"2024","author":"El Mohtarim","year":"2024","journal-title":"J Surg Case Rep"},{"key":"R16-20260928","doi-asserted-by":"crossref","first-page":"562","DOI":"10.21037\/tau.2019.09.46","article-title":"Ewing\u2019s sarcoma\/primitive neuroectodermal tumor of the kidney: a case report and literature review","volume":"8","author":"Zhang","year":"2019","journal-title":"Transl Androl Urol"},{"key":"R17-20260928","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ccell.2021.04.001","article-title":"STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma","volume":"39","author":"Surdez","year":"2021","journal-title":"Cancer Cell"},{"key":"R18-20260928","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1200\/JCO-25-00157","article-title":"Molecular characterization informs prognosis in patients with localized Ewing sarcoma: a report from the Children\u2019s Oncology Group","volume":"43","author":"Gillani","year":"2025","journal-title":"J Clin Oncol"},{"key":"R19-20260928","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1200\/JCO.2005.02.081","article-title":"Ewing sarcomas with p53 mutation or p16\/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse","volume":"23","author":"Huang","year":"2005","journal-title":"J Clin Oncol"},{"key":"R20-20260928","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/cncr.31919","article-title":"Risk stratification by somatic mutation burden in Ewing sarcoma","volume":"125","author":"Liu","year":"2019","journal-title":"Cancer"},{"issue":"suppl 6","key":"R21-20260928","doi-asserted-by":"crossref","first-page":"e30583","DOI":"10.1002\/pbc.30583","article-title":"Children\u2019s Oncology Group\u2019s 2023 blueprint for research: bone tumors","volume":"70","author":"Reed","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"R22-20260928","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/cncr.29065","article-title":"Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children\u2019s Oncology Group","volume":"121","author":"DuBois","year":"2015","journal-title":"Cancer"},{"key":"R23-20260928","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2022.07.1840","volume":"115","author":"Ahmed","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:00:32Z","timestamp":1790622032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003244","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"2025-12-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}